HK1207154A1 - -脂聯素複合物及其用途 - Google Patents

-脂聯素複合物及其用途

Info

Publication number
HK1207154A1
HK1207154A1 HK15107665.2A HK15107665A HK1207154A1 HK 1207154 A1 HK1207154 A1 HK 1207154A1 HK 15107665 A HK15107665 A HK 15107665A HK 1207154 A1 HK1207154 A1 HK 1207154A1
Authority
HK
Hong Kong
Prior art keywords
adiponectin complex
adiponectin
complex
Prior art date
Application number
HK15107665.2A
Other languages
English (en)
Inventor
Iichiro Shimomura
Tohru Funahashi
Ken Kishida
Hironori Kobayashi
Shigeo Takahashi
Original Assignee
Univ Osaka
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Osaka filed Critical Univ Osaka
Publication of HK1207154A1 publication Critical patent/HK1207154A1/zh

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/5759—Products of obesity genes, e.g. leptin, obese (OB), tub, fat
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/472—Complement proteins, e.g. anaphylatoxin, C3a, C5a
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4716—Complement proteins, e.g. anaphylatoxin, C3a, C5a
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/323—Arteriosclerosis, Stenosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Obesity (AREA)
  • Rheumatology (AREA)
  • Rehabilitation Therapy (AREA)
  • Peptides Or Proteins (AREA)
HK15107665.2A 2012-03-30 2015-08-08 -脂聯素複合物及其用途 HK1207154A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2012078540 2012-03-30
PCT/JP2013/059467 WO2013147123A1 (ja) 2012-03-30 2013-03-29 Ｃ１ｑ－アディポネクチン複合体及びその利用

Publications (1)

Publication Number Publication Date
HK1207154A1 true HK1207154A1 (zh) 2016-01-22

Family

ID=49260365

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15107665.2A HK1207154A1 (zh) 2012-03-30 2015-08-08 -脂聯素複合物及其用途

Country Status (5)

Country Link
US (2) US20150050675A1 (zh)
EP (1) EP2837938A4 (zh)
JP (1) JP6141257B2 (zh)
HK (1) HK1207154A1 (zh)
WO (1) WO2013147123A1 (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6923212B2 (ja) * 2016-02-17 2021-08-18 国立大学法人 東京医科歯科大学 動脈硬化性疾患の発症の予測因子および検査方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2713349B2 (ja) * 1989-04-11 1998-02-16 キリン―アムジエン・インコーポレーテツド ヒトｇ―ｃｓｆの測定方法
US7972872B2 (en) * 2004-06-07 2011-07-05 Denka Seiken Co., Ltd. Chromatography detection apparatus, detection method, and kit utilizing the same
WO2009078151A1 (ja) 2007-12-14 2009-06-25 Otsuka Pharmaceutical Co., Ltd. 高分子アディポネクチン測定法
US20100330600A1 (en) * 2008-02-29 2010-12-30 Sekisui Medical Co., Ltd. High-molecular-weight adiponectin measurement method

Also Published As

Publication number Publication date
JPWO2013147123A1 (ja) 2015-12-14
US20170082620A1 (en) 2017-03-23
WO2013147123A1 (ja) 2013-10-03
US20150050675A1 (en) 2015-02-19
EP2837938A1 (en) 2015-02-18
EP2837938A4 (en) 2015-10-21
JP6141257B2 (ja) 2017-06-07

Similar Documents

Publication Publication Date Title
HK1202545A1 (zh) 新型二氮雜螺環烷烴和氮雜螺環烷烴
HK1203493A1 (zh) 取代的氮雜雙環及其用途
HK1199023A1 (zh) 取代的苯並噻吩基-吡咯並三嗪及其用途
HK1200822A1 (zh) 取代的聯吡啶胺及其用途
EP2829480A4 (en) FEEDING AND COUNTERING DEVICE FOR MEDICINAL PRODUCTS
EP2828258A4 (en) NOVEL PYRIDOPYRIMIDINE DERIVATIVES AND THEIR USE
IL239369A0 (en) Pyrocyclic morphines and their use
HK1210949A1 (zh) 組合及其用途
EP2903754A4 (en) SHOVEL AND ITS USE
HK1191034A1 (zh) -羧烷基耳他汀類及其應用
GB201216649D0 (en) Agents and methods
HK1203198A1 (zh) 取代的苯基咪唑並吡唑及其用途
EP2887928A4 (en) RETINOIDS AND USES THEREOF
HK1210809A1 (zh) β己糖基轉移酶及其用法
HK1201050A1 (zh) 多肽和它們的用途
GB201301571D0 (en) Product and use
HK1207154A1 (zh) -脂聯素複合物及其用途
ZA201502159B (en) Mycobacterial thiolperoxidase and its use
GB201222541D0 (en) Kiddibidet and pottibidet
IL218974A0 (en) Conaction bitwen coutch and playels
GB201202021D0 (en) Co-sleeper and breastfeeder
EP2922862A4 (en) COMPLEX FORMING MODULATING ACTIVE SUBSTANCES AND USES THEREOF
GB201215414D0 (en) Composition and use
GB201220504D0 (en) Product and use thereof
GB201213726D0 (en) Novel compounds and their use